Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Latest News about US09062X1037
 
Biogen Idec Announces Positive Top-Line Results from Phase 3 Study of Peginterferon Beta-1a in Multiple Sclerosis
January 24, 2013
about BIIB , NEWS
category Benzinga , US09062X1037 , News , and 2 more.
from Latest Articles from Benzinga.com
Biogen Submits Biologics License Application to FDA for First Long-Lasting Factor IX Therapy for Hemophilia B
January 04, 2013
about BIIB , NEWS
category Management , Benzinga , Asset Sales , and 5 more.
from Latest Articles from Benzinga.com
UPDATE: Piper Jaffray Downgrades Biogen Idec to Neutral on Valuation
January 03, 2013
about BIIB
category Benzinga , Piper Jaffray , Pre/Market Outlook , and 5 more.
from Latest Articles from Benzinga.com
Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)
December 28, 2012
about ALXN , AMGN , ARNA , and 15 more.
category US7169331060 , Regeneron Pharmaceuticals , amgen , and 55 more.
from Latest Articles from Benzinga.com
Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)
December 12, 2012
about ALXN , AMGN , ARNA , and 16 more.
category US7169331060 , Regeneron Pharmaceuticals , glaxosmithkline , and 58 more.
from Latest Articles from Benzinga.com
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here